Published in Neuroscience on October 22, 2012
Sex differences in the neurobiology of epilepsy: a preclinical perspective. Neurobiol Dis (2014) 0.91
MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. Front Cell Neurosci (2015) 0.83
Sex Differences Distinguish Intracortical Glutamate Receptor-Mediated Regulation of Extracellular Dopamine Levels in the Prefrontal Cortex of Adult Rats. Cereb Cortex (2014) 0.80
Enriched environment prevents cognitive and motor deficits associated with postnatal MK-801 treatment. Psychopharmacology (Berl) (2014) 0.76
Postnatal MK-801 treatment of female rats impairs acquisition of working memory, but not reference memory in an eight-arm radial maze; no beneficial effects of enriched environment. Psychopharmacology (Berl) (2015) 0.76
Sex differences in brain-derived neurotrophic factor signaling and functions. J Neurosci Res (2017) 0.75
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry (1991) 8.10
NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res (2000) 4.66
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) (2001) 4.52
Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol (2003) 3.88
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science (1998) 3.70
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol (2000) 3.03
The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol (2007) 2.60
Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther (2003) 2.44
Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl (2000) 2.39
The role of the cerebellum in schizophrenia. Biol Psychiatry (2008) 2.39
Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav (1988) 2.17
Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol (2008) 2.09
3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc Natl Acad Sci U S A (1987) 1.79
Specific [3H]phencyclidine binding in rat central nervous system. Proc Natl Acad Sci U S A (1979) 1.69
Animal models of schizophrenia. Br J Pharmacol (2011) 1.60
Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia. Behav Brain Res (2009) 1.60
Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull (2009) 1.45
Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin Psychol Rev (2010) 1.38
Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment (2012) 1.37
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry (2002) 1.34
The amphetamine-induced sensitized state as a model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.34
Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berl) (2004) 1.22
Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci (1990) 1.21
Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res (2009) 1.20
Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther (1999) 1.16
The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Neurotox Res (2006) 1.15
Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas. Clin Schizophr Relat Psychoses (2012) 1.12
Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophr Res (2002) 1.11
Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur J Pharmacol (1982) 1.08
Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biol Psychiatry (1997) 1.07
Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J Pharmacol Exp Ther (1989) 1.06
Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res (2007) 1.03
Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res (2009) 1.00
Is the acute NMDA receptor hypofunction a valid model of schizophrenia? Schizophr Bull (2011) 0.97
Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure. Psychopharmacology (Berl) (1996) 0.97
Gender and schizophrenia. Psychopharmacol Bull (2007) 0.96
Evaluation of serum steroid hormones in schizophrenic patients. Indian J Med Sci (2004) 0.94
The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Brain Res Rev (1995) 0.94
Neurobiology of reproduction in the female rat. A fifty-year perspective. Monogr Endocrinol (1989) 0.94
Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology (1994) 0.93
Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology (2007) 0.92
Sex differences in clinical response to olanzapine compared with haloperidol. Psychiatry Res (2002) 0.90
Hormones and schizophrenia. Curr Opin Psychiatry (2012) 0.88
Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol (1989) 0.88
The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacol (1992) 0.88
Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects. Eur J Pharmacol (1999) 0.88
Effects of dizocilpine (MK-801) on motor activity and memory. Psychopharmacology (Berl) (1998) 0.87
A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. Biol Psychiatry (1999) 0.87
Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour. Neurosci Lett (2011) 0.87
Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav (1994) 0.87
Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome. Behav Brain Res (2009) 0.87
MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm Gen Sect (1990) 0.86
Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology (Berl) (2003) 0.86
Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biol Psychiatry (1996) 0.85
Greater vulnerability to the amnestic effects of ketamine in males. Psychopharmacology (Berl) (2006) 0.84
Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment. Epidemiol Psychiatr Sci (2011) 0.83
Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats. J Neural Transm Gen Sect (1994) 0.83
Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J Neural Transm Gen Sect (1992) 0.81
Sex differences in NMDA receptor mediated responses in rats. Brain Res (1993) 0.81
Testosterone for schizophrenia. Cochrane Database Syst Rev (2007) 0.81
The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801. Neuropharmacology (2006) 0.80
Reciprocal interactions between MK-801, sleep deprivation and recovery in modulating rat behaviour. Behav Brain Res (2010) 0.80
Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol. J Psychopharmacol (2010) 0.79
Menstrual exacerbation of schizophrenia symptoms. Acta Psychiatr Scand (2012) 0.78
Cortico-cerebellar functional connectivity and sequencing of movements in schizophrenia. BMC Psychiatry (2012) 0.78
Effects of ethanol or rimcazole on dizocilpine maleate-induced behaviors in male and female rats. Alcohol (2003) 0.77
Altered responses to dizocilpine maleate administration in ethanol-withdrawn male and female rats. Alcohol (2002) 0.77
Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue. Pharmacol Biochem Behav (1995) 0.77
Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats. Psychopharmacology (Berl) (1996) 0.76
MK-801 induced stereotypies in rats are decreased by haloperidol and increased by diazepam. J Neural Transm Gen Sect (1992) 0.76
Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity. Physiol Behav (2010) 0.76
Effects of age and sex on ketamine-induced hyperactivity in rats. Physiol Behav (2007) 0.76
Determination of serum and brain concentrations of neuroprotective and non-neuroprotective doses of MK-801. J Neurol Sci (1993) 0.76
Role of sex hormones in sex-dependent differences in phencyclidine-induced stereotyped behaviors in rats. Eur J Pharmacol (1984) 0.76
Estrogen, schizophrenia and neurodevelopment. Womens Health (Lond Engl) (2006) 0.76
Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine. Int J Neuropsychopharmacol (2008) 0.75
Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801. Indian J Physiol Pharmacol (1998) 0.75
Morphology of physiologically identified retinogeniculate X- and Y-axons in the cat. J Neurophysiol (1987) 0.99
Effects of gonadectomy and hormone replacement on a spontaneous novel object recognition task in adult male rats. Horm Behav (2008) 0.98
Immunoreactivity for intracellular androgen receptors in identified subpopulations of neurons, astrocytes and oligodendrocytes in primate prefrontal cortex. J Neurobiol (1999) 0.96
Gonadectomy in adult life increases tyrosine hydroxylase immunoreactivity in the prefrontal cortex and decreases open field activity in male rats. Neuroscience (1999) 0.93
Gonadectomy and hormone replacement affects in vivo basal extracellular dopamine levels in the prefrontal cortex but not motor cortex of adult male rats. Cereb Cortex (2010) 0.92
Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats. Neuroscience (2009) 0.81
Perinatal gonadectomy affects corticocortical connections in motor but not visual cortex in adult male rats. J Comp Neurol (1999) 0.77
In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. Neuroscience (2008) 0.77
The effect of cholinergic antagonists on a central response to nicotine. Experientia (1982) 0.75